Select a Region North America

EVERSANA to Present at the 41st Annual J.P. Morgan Healthcare Conference

CHICAGO – January 6, 2023 – Jim Lang, Chief Executive Officer of EVERSANA®, a pioneer of next-generation commercial services to the global life sciences industry, will present at the 41st Annual J.P. Morgan Healthcare Conference in San Francisco, California.

Lang, along with Chief Financial Officer Kelly Baker and Chief Digital Officer Scott Snyder, will be among EVERSANA leaders connecting with analysts and sharing market insights behind the company’s rapid evolution, from just over 1,000 employees in 2018 to more than 7,000 employees across 16 countries in 2022.

Since its launch in 2018, EVERSANA has built the industry’s first fully integrated commercialization solution, serving more than 650 partners ranging from established pharmaceutical companies to emerging start-ups. EVERSANA’s global commercial services are recognized for improving the launch and long-term in-market success for products across more than 50 therapeutic indications, including oncology, as well as advanced digital therapeutics.

“This conference is widely recognized as the global intersection of investment and innovation,” said Lang. “We’re honored to get a chance to tell our story. But more so, we are humbled to share how our pharmaceutical clients are partnering with us as we transform an industry through digital innovation, award-winning client service, and an unwavering commitment to patients.”

Lang will present on Monday, January 9, 2023, at 5:00 p.m. PST. Interested media or investors who wish to schedule a meeting with EVERSANA leadership can contact [email protected].





EVERSANA is the leading independent provider of global services to the life sciences industry. The company’s integrated solutions are rooted in the patient experience and span all stages of the product life cycle to deliver long-term, sustainable value for patients, prescribers, channel partners and payers. The company serves more than 650 organizations, including innovative start-ups and established pharmaceutical companies, to advance life sciences solutions for a healthier world. To learn more about EVERSANA, visit or connect through LinkedIn and Twitter.




Matt Braun
Director, Corporate Communications
[email protected]
+1 414-434-4830